RB1 and ciliopathy: As ciliary dysfunction is a common feature in both cancer and ciliopathies, CCDC138 may contribute to disease progression by modulating cilia-dependent pathways, including mTOR and p53/Rb, thereby influencing the TME and cell cycle.